ArticleEffect of Fecal Microbiota Transplant versus Conventional Medications in Treatment of Irritable Bowel Syndrome
ArticleEffect of Fecal Microbiota Transplant versus Conventional Medications in Treatment of Irritable Bowel Syndrome
ArticleTHERAPUTIC EFFICACY OF PROBIOTICS AGAINST EXPERIMENTAL GIARDIASIS: HISTOPATHOLOGICAL, HISTOCHEMICAL AND ULTRASTRUCTURAL CHANGES
ArticleTHERAPUTIC EFFICACY OF PROBIOTICS AGAINST EXPERIMENTAL GIARDIASIS: HISTOPATHOLOGICAL, HISTOCHEMICAL AND ULTRASTRUCTURAL CHANGES
ArticleStudies on the antibacterial effect of probiotics and prebiotics against Staphylococcus aureus and Pseudomonas aeruginosa
ArticleStudies on the antibacterial effect of probiotics and prebiotics against Staphylococcus aureus and Pseudomonas aeruginosa
ArticleEvaluation of the role of combined prebiotic and probiotic supplements as prophylactic and therapeutic agents against experimental giardiasis
ArticleEvaluation of the role of combined prebiotic and probiotic supplements as prophylactic and therapeutic agents against experimental giardiasis
ArticleEvaluation of the relationship between Helicobacter Pylori infection and Irritable Bowel Syndrome
ArticleEvaluation of the relationship between Helicobacter Pylori infection and Irritable Bowel Syndrome
ArticleSTUDY OF THE EFFECT OF LACTOBACILLUS ACID FAST AS A PROPHYLAXIS FOR ENTER-COLITIS FOLLOWING SURGERY FOR HIRSCHSPRUNG’S DISEASE IN CHILDREN
ArticleSTUDY OF THE EFFECT OF LACTOBACILLUS ACID FAST AS A PROPHYLAXIS FOR ENTER-COLITIS FOLLOWING SURGERY FOR HIRSCHSPRUNG’S DISEASE IN CHILDREN
ArticleAssessment of the Therapeutic Effect of Probiotic Lactobacilli Alone and in Combination with Metronidazole in Murine Giardiasis
ArticleAssessment of the Therapeutic Effect of Probiotic Lactobacilli Alone and in Combination with Metronidazole in Murine Giardiasis
ArticleINVESTIGATING THE EFFECT OF PROBIOTICS ON THE GUT MICROBIOME AND ON THE OUTCOME OF FOLFOX CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS
ArticleINVESTIGATING THE EFFECT OF PROBIOTICS ON THE GUT MICROBIOME AND ON THE OUTCOME OF FOLFOX CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS